January/February 2017 | business Of Retinainnovations In Retina
Targeting Tie-2 in patients with wet AMD or diabetic eye disease could allow clinicians to treat patients who have not responded to conventional therapies.
Aron Shapiro; David Hollander, MD; and Lisa Smith
November/December 2016 | business Of Retinainnovations In Retina
Targeting the Visual Cycle: Dry AMD and Stargardt Disease
The visual cycle could be the crucible for treating two important degenerative eye diseases.
Aron Shapiro; David Hollander, MD, MBA; and Andrew Hertsenberg, PhD